2022 forecast: AR, VR poised to send medtech into the next dimension

Virtual reality headsets have been around for years, but for much of their history they have been largely confined to the realm of novelty accessories for high-tech gamers.

While VR and its even more immersive sibling, augmented reality, have been slowly trickling into the field of medicine in recent years, it wasn’t until 2021 that the dam broke and let loose a flood of AR and VR into the industry. The COVID-19 pandemic placed new value on going virtual, and the past year has marked a turning point with many of those far-fetched technologies finally becoming a true reality, backed by a deluge of venture capital funds and regulatory greenlights.

If 2021 was the year that immersive technologies finally found their footing in medtech, it stands to reason that 2022, in turn, will be the year that patients, providers and tech developers finally begin reaping the benefits of AR and VR.

The odds are good: A recent market research report estimated that between 2021 and 2026, the market for VR in healthcare will grow nearly 35% annually, swelling to more than $40 billion by the end of that time. That’s a far cry from the comparatively meager $2.7 billion space that VR carved out in medicine in 2020.

Reality check: Setting the stage for immersive tech’s takeover

Among the areas of medtech already experiencing major VR- and AR-induced changes is ophthalmology. Heru, a spinout from the University of Miami’s Bascom Palmer Eye Institute, spent the year riding that wave. After racking up $30 million in VC funding in May, it launched its re:Vive VR-based vision testing platform in August and had already begun rolling out the second-generation iteration of the platform by November.

The updated platform—accessible via commercially available headsets like those from Microsoft and Magic Leap—performs six tests, looking for color blindness, contrast sensitivity, visual field deficiencies and more. Even more tests are already in the works, including ones that use AR technology to identify the exact gaps in a patient’s field of view, allowing for hyper-personalized vision correction.

By Andrea Park | Fierce MedTech

Image Credit: ipopba / Getty Images

READ MORE

About Peter Coffaro 635 Articles
A growth-driven and strategic executive, Peter Coffaro commands more than 20 years of progressive management success within the orthopedic industry. Recognized by MedReps.com and the World Journal of Orthopedics as one of the top medical sales influencers in the industry; he has 10 years of combined sales management experience and has held positions as a Director, General Manager and Distributor. Peter has worked for some of the top orthopedic companies in the world - Zimmer, DePuy and Stryker. He is also the founder of OrthoFeed: a popular blog that covers orthopedic news and emerging medical technologies. Peter is a three-time Hall of Fame award winner at Johnson and Johnson and has an extensive background in organizational development, business development, sales management, digital marketing and professional education. Peter holds a B.S. degree in Biology from Northern Illinois University.

Be the first to comment

Leave a Reply

Your email address will not be published.


*


This site uses Akismet to reduce spam. Learn how your comment data is processed.